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INTRODUCTION
Given concerns regarding late drug eluting stent (DES) throm-
bosis, imaging modalities have attempted to identify risk fac-
tors for the occurrence of stent thrombosis.1-4 Of these, late 
stent malapposition or incomplete coverage of stent struts af-
ter DES implantation have been suggested as major potential 
risks for late adverse clinical outcomes, such as late stent 
thrombosis.1-5 Additionally, several clinical and procedural 
features after DES implantation have been postulated as po-
tential risk factors for late stent malapposition and incomplete 
coverage of stent struts. Optical coherence tomography (OCT) 
has been used to evaluate these risk factors due to its superior 
resolution over other imaging modalities.4,6,7 Nevertheless, lit-
tle data exists regarding the impact of plaque characteristics or 
composition of de novo lesions on vascular healing responses, 
particularly late stent malapposition or incomplete strut cov-
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Purpose: To evaluate the impact of pre-procedural coronary plaque composition assessed by virtual histology intravascular ultra-
sound (VH-IVUS) on late stent malapposition assessed by optical coherence tomography (OCT) following drug-eluting stent 
(DES) implantation. 
Materials and Methods: The study population consisted of 121 patients (121 lesions) who underwent both pre-procedural VH-
IVUS and follow-up OCT after DES implantation. The association between pre-procedural plaque composition [necrotic core 
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predictor of late stent malapposition on multivariate analysis (β=1.12, p=0.002). There were no significant correlations between 
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Conclusion: Pre-procedural plaque composition was associated with late stent malapposition but not strut coverage after DES 
implantation. Larger pre-procedural absolute total DC plaque volumes were associated with greater late stent malapposition. 
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erage, after DES implantation.8-10
We hypothesized that quantitative assessment of plaque 
composition could predict late stent malapposition or incom-
plete strut coverage after DES implantation. We sought to 
prove this hypothesis by evaluating the association between 
pre-procedural coronary plaque composition on virtual his-
tology intravascular ultrasound (VH-IVUS) and strut malap-
position or coverage on follow-up OCT after DES implanta-
tion.
MATERIALS AND METHODS
Between July 2010 and December 2011, we identified 121 eli-
gible patients (121 lesions) who underwent both pre-proce-
dural VH-IVUS examination on de novo lesions and follow-up 
OCT after DES implantation from an OCT registry database at 
our institute. Patients or lesions with the following character-
istics were excluded from this study: 1) untreated significant 
left main coronary artery disease, bifurcation treated with 
two-stent techniques, in-stent restenosis, graft stenosis, or 
overlapping DES; 2) ST-elevation myocardial infarction; 3) 
hemodynamically unstable status or ejection fraction <30%; 4) 
renal insufficiency with baseline creatinine ≥2.0 mg/dL; and 
5) poor intravascular ultrasound (IVUS) or OCT image quali-
ty. This study protocol was approved by the Institutional Re-
view Board of Yonsei University College of Medicine. All pa-
tients provided written informed consent.
DESs were selected by operators at the time of implantation 
and included sirolimus-eluting stents (Cypher, Cordis, Miami, 
FL, USA), zotarolimus-eluting stents (Resolute or Integrity, 
Medtronic, Santa Rosa, CA, USA), everolimus-eluting stents 
(Xience, Abbott Vascular, Santa Clara, CA, USA), or biolimus 
A9-eluting stents (Nobori, Terumo Corporation, Tokyo, Japan 
or Biomatrix, Biosensors International, Singapore). Each DES 
was implanted with conventional techniques. Unfractionated 
heparin was administered as an initial bolus of 100 IU/kg, 
with additional boluses administered during the procedure to 
achieve an activated clotting time of 250 to 300 seconds. Dual 
antiplatelet therapy (aspirin and clopidogrel) was prescribed 
at least until the follow-up OCT was performed. Quantitative 
coronary angiography analyses were performed before and 
after stent implantation and at follow-up using an off-line 
quantitative coronary angiographic system (CASS system, Pie 
Medical Instruments, Maastricht, the Netherlands) in an inde-
pendent core laboratory (Cardiovascular Research Center, Seoul, 
Korea). Reference vessel diameters and minimal luminal di-
ameters were measured with a guiding catheter for magnifica-
tion-calibration from diastolic frames in a single, matched 
view that showed the smallest minimal luminal diameter.
The VH-IVUS examination was performed in the target le-
sion before pre-dilation using a 20-MHz 2.9 Fr, phased-array 
IVUS catheter (Eagle Eye, Volcano Therapeutics, Rancho Cor-
dova, CA, USA). After intracoronary administration of nitro-
glycerin (200 μg), the IVUS catheter was placed distal to the 
target lesion and then pulled back using a motorized pullback 
system at 0.5 cm/s. During pullback, gray-scale IVUS was re-
corded, and raw radiofrequency data were captured at the top 
of the R wave for reconstruction of a color-coded map by a VH-
IVUS data recorder (Volcano Therapeutics). Gray-scale quanti-
tative IVUS analyses of the external elastic membrane, lumen, 
and plaque and media (external elastic membrane-lumen) 
were performed according to the Clinical Expert Consensus 
Document on IVUS.11 VH-IVUS data were analyzed for the en-
tire length of the target lesion covered by DES with 1-mm in-
tervals for volumetric analysis. On the pre-procedural IVUS 
images, the diseased segment was selected and the references 
were defined as the most normal-appearing segments within 
5 mm proximal and distal to the lesion shoulders. Also, the re-
gion of interest, matched frames of the stented segment on 
follow-up OCT images, was identified based on anatomic 
landmarks, such as side branches or calcification, aided by an-
giographic images revealing the IVUS catheter position. VH-
IVUS analysis coded tissue as red (necrotic core, NC), white 
(dense calcium, DC), green (fibrotic, FT), or yellow-green (fi-
bro-fatty, FF).12,13 The findings of VH-IVUS analyses were de-
scribed as absolute volumes and percentages (relative amounts) 
of plaque volumes. 
OCT was performed using two OCT systems (Model M2 
Imaging System and C7-XR Imaging System, LightLab Imag-
ing, Inc., St. Jude Medical, St. Paul, MN, USA).6,9 All of the OCT 
images were analyzed at a core laboratory (Cardiovascular 
Research Center, Seoul, Korea) by analysts who were blinded 
to patient and procedural information. Cross-sectional OCT 
images were analyzed at 1-mm intervals. Stent and luminal 
cross-sectional areas (CSA) were measured, and neointimal 
hyperplasia (NIH) CSA was calculated as the stent CSA minus 
the luminal CSA.6 Total stent, lumen, and NIH volumes within 
stented segments were calculated. NIH thickness, which was 
the distance between the endoluminal surface of the neointi-
ma and the strut, was measured inside each strut with a line 
perpendicular to the neointima and strut.14 An uncovered 
strut was defined as having a NIH thickness of 0 μm.7,14,15 Stent 
malapposition was defined as the presence of any malap-
posed struts.15-17 A malapposed strut was defined as a strut 
that was detached from the vessel wall as follows: Cypher, 
≥160 μm; Resolute or Integrity, ≥110 μm; Xience, ≥100 μm; 
and Nobori or Biomatrix, ≥130 μm.15-19 The percent of malap-
posed or uncovered struts in each stented lesion was calculat-
ed as: (number of malapposed or uncovered struts/total 
number of struts in all cross-sections of the lesion)×100.7 
Continuous data are presented as mean±standard devia-
tion, and categorical data are presented as number (%). Pear-
son’s two-way test was used to assess the relationships be-
tween two quantitative variables. Each pre-procedural plaque 
component (NC, DC, FT, and FF) was classified into quartiles. 
http://dx.doi.org/10.3349/ymj.2015.56.6.15381540
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Analysis of variance was used to compare the percentage of 
malapposed or uncovered struts according to each plaque 
component quartile. Multivariate analysis was performed to 
determine the independent predictors of late stent malappo-
sition. Variables that reached a p<0.1 in univariate analysis 
were included in a multivariate forward stepwise regression 
analysis. Statistical analysis was performed with SPSS soft-
ware, version 18.0 (SPSS Inc., Chicago, IL, USA), and a p-value 
<0.05 was considered statistically significant.
 
RESULTS
Clinical, procedural, and pre-procedural VH-IVUS character-
istics according to the presence of late stent malapposition are 
summarized in Table 1 and 2. Follow-up OCT characteristics 
are summarized in Table 3. Pre-procedural absolute total NC 
and DC plaque volumes were positively correlated with the 
percentage of malapposed struts (r=0.44, p<0.001, Fig. 1A and 
r=0.45, p<0.001, Fig. 1B, respectively), and pre-procedural ab-
solute total FT plaque volume was weakly associated with the 
percentage of malapposed struts (r=0.220, p=0.015). When 
each relative total plaque volume was classified into quartiles 
according to the plaque components, the highest NC plaque 
volume quartile and the highest DC plaque volume quartile 
had a significantly higher percentage of malapposed struts 
(p=0.013 for relative NC plaque volume, p=0.020 for relative 
DC plaque volume) (Fig. 2A). The highest FT plaque volume 
quartile had a lower percentage of malapposed struts (p=0.040). 
The lesions with stent malapposition on follow-up OCT had a 
Table 1. Baseline Clinical and Procedural Characteristics
 
Overall,
n=121
Late stent 
malapposition (+),
n=37
Late stent
malapposition (-),
n=84
p value
Age, yr 61±9 63±8 60±10 0.063
Male, n (%) 88 (73) 29 (78) 59 (70) 0.354
Clinical presentation, n (%) 0.205
Stable angina 78 (65) 27 (73) 51 (61)
Unstable angina 25 (20) 4 (11) 21 (25)
Non-ST elevation myocardial infarction 18 (15) 6 (16) 12 (14)
Hypertension, n (%) 74 (61) 27 (73) 47 (56) 0.077
Diabetes mellitus, n (%) 42 (35) 11 (30) 31 (37) 0.445 
Dyslipidemia, n (%) 67 (55) 27 (73) 40 (48) 0.010 
Current smoker, n (%) 31 (26) 10 (27) 21 (25) 0.814 
Target lesions, n (%) 0.357
Left anterior descending 73 (60) 22 (60) 51 (61)
Left circumflex 20 (17) 4 (11) 16 (19)
Right coronary artery 28 (23) 11 (30) 17 (20)
Presence of thrombus on angiography 9 (7) 2 (5) 7 (8) 0.572
Reference vessel diameter, mm 3.1±0.5 3.3±0.4 3.0±0.5 0.024
Pre-procedural minimal lumen diameter, mm 1.2±0.4 1.3±0.5 1.1±0.3 0.136
Post-procedural minimal lumen diameter, mm 2.9±0.4 2.9±0.3 2.8±0.4 0.209
Post-procedural diameter stenosis, % 9.0±7.4 10.7±5.4 8.3±8.1 0.119
Follow-up minimal lumen diameter, mm 2.7±0.5 2.8±0.5 2.6±0.5 0.050
Follow-up diameter stenosis, % 9.9±13 7.7±11.9 10.9±12.7 0.192
Lesion length, mm 16.4±4.6 18.0±4.6 15.7±4.4 0.027
Plaque modification procedure 0 0 0 1.000
Stent diameter, mm 3.2±0.4 3.3±0.3 3.2±0.4 0.250 
Stent length, mm 19.1±4.6 20.5±4.8 18.5±4.5 0.035 
Stent type, n (%) 0.852 
Sirolimus-eluting stent 36 (30) 12 (32) 24 (29)
Zotarolimus-eluting stent 31 (26) 10 (27) 21(25)
Everolimus-eluting stent 8 (7) 3 (8) 5 (6)
Biolimus-eluting stent 46 (38) 12 (32) 34 (41)
Post-dilation, n (%) 82 (68) 26 (70) 56 (67) 0.696
Maximal dilated pressure, atm 17.6±3.5
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significantly larger initial absolute total NC plaque volume 
(30.7±22.3 mm3 vs. 19.5±16.4 mm3, p=0.008) and absolute to-
tal DC plaque volume (12.3±14.5 mm3 vs. 5.9±5.4 mm3, p= 
0.012) (Table 2). Similarly, the lesions with stent malapposi-
tion had a significantly larger relative total NC plaque volume 
(22.1±8.7% vs. 17.4±8.9%, p=0.009) and a larger relative total 
DC plaque volume (8.6±5.9% vs. 5.9±4.5%, p=0.008) (Table 2). 
On the pre-procedural IVUS images, among the 37 lesions with 
late stent malapposition, superficial calcium was observed in 
24 lesions (65%) and deep calcium was observed in eight le-
sions (21%). The remaining five lesions (14%) did not have cal-
cium. Also, the mean calcium length of the 31 calcified lesions 
was 8.9±8.3 mm, and the proportion of calcium length with re-
gard to total lesion length was 44±30%.
As for the percentage of uncovered struts, there was no sig-
nificant relationship with absolute total NC plaque volume 
(r=0.11, p=0.227) (Fig. 1C) or absolute total DC plaque volume 
(r=0.15, p=0.102) (Fig. 1D). Similarly, there were no significant 
differences in the percentage of uncovered struts among the rel-
ative total volume quartiles of each plaque component (Fig. 2B). 
On multivariate analyses, pre-procedural absolute total DC 
plaque volume was the only independent predictor of late 
stent malapposition (β=1.12, p=0.002). 
DISCUSSION 
The main findings of the present study were as follows: 1) pre-
procedural quantitative assessment of plaque composition by 
VH-IVUS may predict the degree of late stent malapposition 
detected by OCT; 2) greater pre-procedural DC plaque bur-
den was associated with greater late stent malapposition and 
was the only independent predictor for late stent malapposi-
tion; and 3) pre-procedural plaque composition was not asso-
ciated with strut coverage on follow-up OCT after DES im-
plantation. 
Until now, there has been little data regarding the associa-
tion between pre-procedural plaque composition evaluated 
by VH-IVUS and strut coverage on follow-up OCT after DES 
implantation. Even though plaque characteristics seem to 
strongly affect vascular healing responses after DES implanta-
tion, no data exists regarding the impact of plaque character-
istics on late stent malapposition or coverage of struts, which 
may be considered potential risk factors for the occurrence of 
late stent thrombosis.1-5 In addition, many previous OCT stud-
ies evaluating vascular responses after DES implantation have 
commonly been limited by a lack of information regarding 
pre-procedural plaque characteristics of de novo lesions.16,17 
Given this situation, we sought to investigate the impact of 
plaque characteristics of de novo lesions on vascular respons-
es following DES implantation using pre-procedural VH-IVUS 
and follow-up OCT. 
Mechanisms of late persistent malapposition have been 
proposed. Malapposition might be mediated partly by calci-
fied lesions that do not allow for homogeneous stent expan-
sion and could result in the lack of contact of stent struts with 
the vessel walls.1 Also, as for plaque characteristics affecting 
the occurrence of stent malapposition, a recent OCT study re-
Table 2. Pre-Procedural VH-IVUS 
Total,
n=121
Late stent
malapposition (+),
n=37
Late stent
malapposition (-),
n=84
p value
Pre-procedural gray-scale IVUS characteristics
Target lesion CSA with minimum lumen area
EEM CSA, mm2 13.0±4.1 14.2±4.1 12.4±4.1 0.028 
Lumen CSA, mm2 2.7±0.9 3.2±1.2 2.5±0.6 0.003 
P&M CSA, mm2 10.2±4.0 11.0±3.8 9.9±4.0 0.139 
Plaque burden, % 77.3±9.0 76.5±9.2 77.6±8.9 0.529 
Pre-procedural VH-IVUS characteristics
Absolute total plaque volume, mm3
Necrotic core 22.9±19.0 30.7±22.3 19.5±16.4 0.008 
Dense calcium 7.9±9.6 12.3±14.5 5.9±5.4 0.012 
Fibrotic 63.8±33.8 68.1±28.7 61.9±35.8 0.358 
Fibrofatty 16.5±12.4 16.5±13.1 16.6±12.1 0.973 
Relative total plaque volume, %
Necrotic core 18.9±9.1 22.1±8.7 17.4±8.9 0.009 
Dense calcium 6.7±5.1 8.6±5.9 5.9±4.5 0.008 
Fibrotic 59.3±9.8 56.4±9.8 60.5±9.6 0.031 
Fibrofatty 15.1±10.3 12.7±7.8 16.2±11.1 0.081 
IVUS, intravascular ultrasound; EEM, external elastic membrane; CSA, cross-sectional area; P&M, plaque and media; VH, virtual histology.
Values were presented as mean±standard deviation. 
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Fig. 1. Correlation between absolute total plaque component volumes and percentage of malapposed (A and B) or uncovered struts (C and D) on fol-
low-up OCT. Absolute total NC plaque volume and absolute total DC plaque volume were positively correlated with percentage of malapposed struts 
but not with percentage of uncovered struts. OCT, optical coherence tomography; NC, necrotic core; DC, dense calcium. 
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Fig. 2. Percentage of malapposed (A) and uncovered struts (B) according to the relative total plaque volume quartiles of each plaque component. The 
highest relative NC plaque volume quartiles and the highest relative DC plaque volume quartiles had a significantly higher percentage of malapposed 
struts. NC, necrotic core; DC, dense calcium; FT, fibrotic; FF, fibrofatty. 
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ported that the presence of calcium was one independent 
predictor of late persistent stent malapposition after DES im-
plantation.6 Therefore, although we could not classify late 
stent malapposition into late-acquired and persistent malap-
position in the present study, larger DC volumes may be im-
portant for late persistent stent malapposition. Other IVUS 
studies have suggested that late-acquired stent malapposition 
occurs mainly due to positive remodeling and plaque/throm-
bus resolution.20,21 In the present study, we found that abso-
lute total NC plaque volume is also positively related to the 
degree of late stent malapposition in univariate analysis. Thus, 
larger NC volumes may be important for late-acquired stent 
malapposition. Similar to our study, a previous study reported 
that a post-stented NC component was associated with the 
development of late stent malapposition on follow-up IVUS 
after DES implantation, particularly in patients with acute 
myocardial infarction and diabetes mellitus.22 However, the 
present study is different from the previous study in that we 
assessed the plaque characteristics pre-intervention, not post-
intervention. Furthermore, we assessed vascular healing re-
sponses using OCT, not IVUS, which might weight the impor-
tance of this study. Our study showed that pre-procedural 
plaque composition may play an essential role in formation of 
late stent malapposition after DES implantation. 
Late stent thrombosis after DES implantation is a serious 
concern because of delayed vascular healing and inflamma-
tory reaction. Uncovered struts on follow-up OCT have been 
proposed as potential risk factors for late stent thrombosis af-
ter DES implantation.4,5 A previous study showed that cover-
Table 3. Pre-Procedural VH-IVUS and Matched Follow-Up OCT Charac-
teristics
Follow-up OCT characteristics Total, n=121
Time interval to follow-up OCT, months 6.3±3.1
Total mean number of cross sections, n 17.2±5.0
Total mean number of analyzable struts, n 189±58
Mean stent CSA, mm2 7.5±2.0
Mean lumen CSA, mm2 7.0±2.0
Mean NIH CSA, mm2 0.5±0.4
Percentage of NIH CSA, % 6.5±5.3
Median NIH thickness, μm 54.5 (35.1–96.3)*
Percent malapposed struts, % 0.8±2.5
Percent uncovered struts, % 15.3±16.7
Percentage of both of malapposed and uncovered  
  struts, %
0.5±1.8
Cross sections with any uncovered strut, % 31.1±37.6
Cross sections with a ratio of uncovered to total  
  strut >0.3, %
15.4±26.9
Cross sections with any malapposed strut, % 3.0±9.5
Stent malapposition, n (%) 37 (31)
OCT, optical coherence tomography; CSA, cross-sectional area; NIH, neointi-
mal hyperplasia; VH-IVUS, virtual histology intravascular ultrasound.
*Was presented as median (interquartile range). 
age of malapposed stent segments is delayed, compared to 
well-apposed segments, and that the larger the acute malap-
position, the greater the likelihood of persistent malapposi-
tion and delayed healing at follow-up.4 Thus, we hypothesized 
that plaque composition, particularly a DC or NC component, 
may result in delayed strut coverage. However, in the present 
study, there were no significant associations between the spe-
cific plaque components and strut coverage after DES im-
plantation. Considering the results of our previous OCT study, 
DES type rather than plaque characteristics on VH-IVUS may 
be the more powerful factor in determining strut coverage.7 
This study has several limitations. First, it was not clear 
whether the malappositions at follow-up were residual or 
newly acquired because post-procedural intravascular imag-
ing studies were not preformed immediately after DES im-
plantation. Second, this study was based on registry data, and 
the sample size was quite small. Finally, different types of DES 
were used. 
In conclusion, pre-procedural assessment of plaque com-
position by VH-IVUS may predict the formation of late stent 
malapposition detected by OCT at follow-up. Larger pre-pro-
cedural DC plaque volumes were associated with late stent 
malapposition. However, pre-procedural plaque composition 
was not associated with decreased strut coverage at follow-up 
after DES implantation.
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